Tuberculosis Testing Market Expected to Reach USD 2.62 Billion Globally in 2020
Summary: Tuberculosis Testing Market (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing (DST) and Other TB Tests): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020
According to a new market report published by Transparency Market Research “Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” the global tuberculosis testing market was valued at USD 1,936.1 million in 2013 and is expected to grow at a CAGR of 4.3% from 2014 to 2020, to reach an estimated value of USD 2,619.4 million in 2020.
Tuberculosis (TB) accounts for a large share of the global infectious disease burden. The disease was most widespread between 1950s and 1960s across the world and the WHO declared TB as a global emergency in 1993. However, due to the continuous and effective control measures and programs such as Stop TB and DOTS (Directly Observed Treatment, Short-course) most developed nations have been able to minimize the spread of this disease. Tuberculosis is still highly prevalent in many parts of the world affecting millions of lives, especially in Asia and Africa.
TB is a highly contagious disease and is the second leading cause of death, after human immunodeficiency virus (HIV). Active tuberculosis and latent tuberculosis are the two most common forms of TB that affect individuals. Over the time, TB has also developed into more diverse and potent forms that are referred as multi-drug resistant (MDR) or extensively drug resistant (XDR) TB. These conditions are also spreading at a rapid rate and require extensive diagnostic and treatment measures to check its spread worldwide. Various tuberculosis testing procedures and equipment are currently available in the global market. Improved and technologically advanced TB testing...